CARDIVAS CR-40 – CAP

Description

Cardivas CR-40 Capsule is a controlled-release (CR) formulation containing Carvedilol 40mg, a potent beta-blocker with alpha-1 blocking properties. This extended-release capsule ensures a steady and gradual release of carvedilol, improving patient compliance by allowing once-daily dosing and maintaining stable blood concentrations.

It is indicated for the treatment of:

• Hypertension (high blood pressure)

• Chronic heart failure

• Stable angina pectoris

• Reduction of risk for cardiovascular complications post-myocardial infarction

Carvedilol works by blocking beta-adrenergic and alpha-1 receptors, leading to decreased heart rate, vasodilation, and reduced cardiac workload. This helps in lowering blood pressure and improving heart function.

Key Benefits:

• Convenient once-daily dosing due to controlled-release technology

• Provides steady blood levels for consistent therapeutic effects

• Effective management of hypertension and heart failure symptoms

• Reduces risk of cardiac events and improves quality of life

Dosage & Administration:
Take the capsule once daily with food, ideally at the same time each day. Do not crush or chew the capsule to preserve the controlled-release mechanism.

Common Side Effects:
Possible side effects include dizziness, fatigue, bradycardia (slow heartbeat), hypotension (low blood pressure), cold extremities, and mild gastrointestinal discomfort. Seek medical attention if serious side effects occur.

Precautions:

• Use cautiously in patients with asthma, diabetes, liver or kidney impairment

• Not recommended for pregnant or breastfeeding women unless specifically advised

• Regular monitoring of blood pressure, heart rate, and blood glucose levels is recommended